In HCC, elevated TGM2 expression correlates with poor differentiation, high levels of the HCC marker alpha-fetoprotein (AFP), and advanced tumor stage, with pharmacological inhibition of serotonylation suppressing tumor growth 321. The gene discussed is AFP; the disease is neoplasm.